Editas Medicine (EDIT) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 17, 2026, with voting open until June 16, 2026.

• Shareholders can access proxy materials online or request paper/email copies by June 3, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of two Class I Directors, Bernadette Connaughton and Elliott Levy, M.D., to serve until the 2029 annual meeting.

• Advisory vote to approve compensation for named executive officers.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.

• Board recommends voting in favor of all proposals.

Board of directors and corporate governance

• Two director nominees are up for election to serve a three-year term, expiring at the 2029 annual meeting.